Chen Luo | Electron microscopy analysis | Best Researcher Award

Posted on by sciencefather

Dr. Chen Luo | Electron microscopy analysis | Best Researcher Award

Assistant Dean at Wuxi University, China

Chen Luo is a distinguished researcher in the field of electron microscopy analysis, renowned for his extensive contributions to materials science and device physics. With a strong foundation in advanced characterization techniques, he has successfully led several high-profile research initiatives and collaborated with top-tier international journals. His work reflects a deep commitment to innovation, scientific excellence, and the advancement of electron microscopy technologies.

profile

scopus

Education

Chen Luo pursued his academic journey with a strong focus on materials science and engineering. Through rigorous training and dedicated research efforts during his undergraduate and postgraduate studies, he built a solid expertise in electron microscopy, nanotechnology, and device fabrication. His educational background has been instrumental in shaping his research pursuits and contributions to the field.

Experience

With a rich career in both academic research and applied science, Chen Luo has amassed considerable experience in electron microscopy analysis. He has presided over four major research projects, including those funded by the National Natural Science Foundation of China. Additionally, he serves as a reviewer for high-impact journals, ensuring the dissemination of quality research in the scientific community. His professional journey is marked by leadership in research, mentorship of emerging scholars, and contributions to international scientific dialogues.

Research Interest

Chen Luo’s research interests span across advanced electron microscopy techniques, nanomaterials, semiconductor devices, and materials characterization. His work often explores the intersection of physical properties and microstructural features, aiming to develop cutting-edge applications in electronics and energy devices. He is particularly interested in pushing the boundaries of microscopy resolution and accuracy to uncover new insights into material behaviors at the nanoscale.

Award

Chen Luo’s scientific achievements have been recognized through multiple accolades. Notably, he has been honored for his groundbreaking work in electron microscopy and material science. His leadership in key research projects and his significant publication record underline his eligibility for prestigious awards and honors in the scientific community.

Publication

Chen Luo has published 51 SCI-indexed papers in the field of electron microscopy analysis, with 9 papers authored as the first author, advisor-first author, or corresponding author. Selected publications include:

“High-Resolution Electron Microscopy of Two-Dimensional Materials,” Advanced Materials, 2018, cited by 102 articles.

“Nanoscale Electrical Properties of Semiconductor Devices,” IEEE Transactions on Electron Devices, 2019, cited by 87 articles.

“Graphene-Based Heterostructures for Nanoelectronics,” Small, 2020, cited by 95 articles.

“Atomic-Level Characterization of Defects in Energy Materials,” ACS Nano, 2021, cited by 78 articles.

“In-Situ Observation of Phase Transitions in 2D Materials,” Nano Letters, 2022, cited by 55 articles.

“Electron Microscopy Insights into Battery Materials,” Journal of Materials Chemistry A, 2023, cited by 43 articles.

“Advanced Techniques for 3D Electron Microscopy,” Microscopy and Microanalysis, 2023, cited by 36 articles.
These works collectively emphasize his role in advancing both the theoretical and applied aspects of electron microscopy.

Conclusion

Chen Luo’s outstanding academic achievements, innovative research output, and dedicated service to the broader scientific community make him a highly deserving recipient of the Best Researcher Award. His consistent excellence and leadership in electron microscopy analysis have not only advanced his field but have also set a benchmark for aspiring researchers.

Bahar KEFELİ ÇOL | E-Health Literacy | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Bahar KEFELİ ÇOL | E-Health Literacy | Best Researcher Award

Assistant Professor at Recep Tayyip Erdoğan University Güneysu School of Physical Therapy and Rehabilitation, Turkey

Assistant Professor Dr. Bahar Kefeli Çol is a distinguished academic and researcher at Recep Tayyip Erdoğan University, currently serving at the Güneysu School of Physical Therapy and Rehabilitation. With more than 15 years of experience spanning healthcare and academia, she has made significant contributions to the field of public health nursing. Her journey began as a midwife-nurse in a private hospital, and she quickly advanced into academia, where she has built a prolific career grounded in teaching, research, and interdisciplinary engagement. Dr. Çol has become a respected figure in areas ranging from health promotion to psychosocial health, and she continues to influence the scientific community through research, book authorship, and active participation in global academic discussions.

profile

google scholar

Education

Dr. Çol holds both a Master’s and Ph.D. in Public Health Nursing, providing a robust foundation for her scholarly pursuits. Her academic progression reflects a dedicated commitment to the field of nursing, with a specialized focus on community-based health, evidence-based practice, and behavioral health. Her postgraduate studies deeply explored the intersections of healthcare delivery, health psychology, and education, enabling her to foster both theoretical and applied knowledge in the realm of public health.

Experience

Dr. Çol’s professional background is characterized by a blend of clinical practice and academic instruction. Starting her career in a clinical setting as a midwife-nurse, she transitioned to academic roles including research assistant and lecturer. Since 2017, she has served as an Assistant Professor, designing and delivering curriculum content while mentoring students in health sciences. Her teaching philosophy emphasizes the integration of research findings into nursing education and the cultivation of critical thinking among healthcare professionals.

Research Interest

Her primary research interests revolve around public health nursing, health promotion, and digital health literacy. She has conducted influential studies on health-related behaviors, the psychological impact of pandemics and disasters, and the role of complementary and integrative therapies in patient care. Additionally, her work addresses health anxiety, cyberchondria, aging, cancer survivorship, school health, and attitudes toward violence. These diverse interests are tied together by a commitment to enhancing individual and community well-being through interdisciplinary health strategies.

Awards

Although she has not yet received a formal award, Dr. Çol’s scholarly contributions and growing citation record reflect her rising impact in the field. She is a first-time nominee for the Best Researcher Award, a recognition that aligns with her ongoing dedication to advancing research that bridges clinical practice and health education.

Publications

Dr. Çol has published in high-impact, peer-reviewed journals, with articles increasingly cited in interdisciplinary fields. Among her notable works:

The Relationship Between Tranquility Level and Professional Satisfaction in Nurses, J Nurs Manag, 2025 – Cited by 8 articles.

E-Health Literacy, Health Anxiety, Cyberchondria, and Death Anxiety in Health Students, J Multidiscip Healthc, 2025 – Cited by 10 articles.

Health Promotion Training Effects on Students’ Behavior, Front Psychol, 2024 – Cited by 15 articles.

Intimate Partner Violence and Hope Among Health Students, Risk Manag Healthc Policy, 2024 – Cited by 6 articles.

Elderly Discrimination and Aging Views in Health Fields, J Multidiscip Healthc, 2024 – Cited by 7 articles.

Complementary Therapy Use in Health Students, Heliyon, 2024 – Cited by 9 articles.

Psychological Impact of COVID-19, AIMS Public Health, 2023 – Cited by 12 articles.

These publications demonstrate a consistent focus on nursing education, student behavior, digital health, and social-psychological dynamics in healthcare.

Conclusion

Dr. Bahar Kefeli Çol exemplifies the qualities of a Best Researcher Award recipient through her academic integrity, focused research addressing critical public health issues, and a strong publication record that spans diverse and socially relevant topics. Her scholarly dedication, particularly in enhancing healthcare outcomes and health literacy, makes her a deserving nominee for this prestigious recognition.

Erin Sheets | Clinical Psychology | Best Researcher Award

Posted on by sciencefather

Dr. Erin Sheets | Clinical Psychology | Best Researcher Award

Associate Professor of Psychology at Colby College, United States

Erin S. Sheets is an esteemed Associate Professor of Psychology at Colby College, known for her pioneering research on social belonging, stress, and mental health in emerging adults. As both an academic and licensed clinical psychologist, she bridges rigorous research and compassionate practice, with special focus on interventions that support underrepresented students. With a career that spans university teaching, clinical service, and funded research, Dr. Sheets has made lasting contributions to the fields of clinical psychology, higher education mental health, and stress research.

profile

orcid

Education

Dr. Erin S. Sheets earned her A.B. magna cum laude in Psychology and Spanish from Duke University in 2001, and then completed her M.A. (2004) and Ph.D. (2008) in Clinical Psychology at the University of Colorado at Boulder. She enhanced her clinical acumen through an internship at Brown University’s Clinical Psychology Training Consortium (2007-2008) and a postdoctoral fellowship at Brown University and Butler Hospital, specializing in mood disorders and perinatal mental health. This comprehensive academic foundation has provided her with deep expertise in both research and clinical application.

Experience

Dr. Sheets has developed her professional career through diverse roles in academia and clinical practice. She joined Colby College in 2010 as an Assistant Professor of Psychology and advanced to Associate Professor in 2017, a position she continues to hold. Between 2017 and 2021, she also worked as a licensed psychologist at Psychology Specialists of Maine. Her academic career includes a Visiting Scholar position at UCLA’s Department of Psychology in 2014. Through her roles, she has combined clinical psychology knowledge with research-driven teaching, significantly shaping both student learning and scholarly discourse.

Research Interest

Dr. Sheets’ research primarily explores the relationship between social belonging, stress, and mental health outcomes in emerging adults, with particular focus on college students from marginalized backgrounds such as BIPOC and first-generation learners. Her studies often examine stress reactivity, depression vulnerability, and interventions that strengthen resilience and emotional regulation. She has secured multiple research grants, including funding from the Spencer Foundation, to study brief group-based social belonging interventions and their long-term impact on mental health and academic performance.

Award

Dr. Sheets has been recognized through substantial external and internal research funding, including the prestigious Spencer Foundation Small Research Grant for her project on social belonging and mental health in disadvantaged college students. Additionally, she has received multiple Social Science Divisional Research Grants from Colby College to advance her research on emotional dynamics, stress, and academic resilience. These awards underscore her commitment to advancing mental health support for young adults through evidence-based, accessible interventions.

Publication

Dr. Sheets has published extensively in peer-reviewed journals, making significant scholarly contributions to the fields of psychology and mental health. Selected recent publications include:

Asnes, S., & Sheets, E. S. (2025). Social media content about anxiety, theories of anxiety, and coping strategies in college students. Journal of American College Health. (Cited by 2).

Sheets, E. S., & Young, D. (2024). A brief, group social belonging intervention to improve mental health and academic outcomes in BIPOC and first-generation to college students. Clinical Psychological Science. (Cited by 8).

Huebschmann, N. A., & Sheets, E. S. (2021). Don’t fear conflict: Relationship stress beliefs in friend, familial, and romantic relationships. Psi Chi Journal of Psychological Research. (Cited by 4).

Sheets, E. S., & Armey, M. F. (2020). Daily interpersonal and noninterpersonal stress reactivity in current and remitted depression. Cognitive Therapy and Research. (Cited by 11).

Huebschmann, N. A., & Sheets, E. S. (2020). The right mindset: Stress mindset moderates the association between perceived stress and depressive symptoms. Anxiety, Stress, & Coping. (Cited by 9).

Wenze, S. J., Gaugler, T. L., Sheets, E. S., & DeCicco, J. M. (2018). Momentary experiential avoidance. Behaviour Research and Therapy. (Cited by 20).

Rabasco, A. N., & Sheets, E. S. (2016). The effects of face-to-face and online social stress on emotion identification. Modern Psychological Studies. (Cited by 3).

Conclusion

 Dr. Erin S. Sheets’ profound contributions to psychological science, her ongoing dedication to nurturing student scholarship, and her ability to translate research into real-world impact position her as an exemplary candidate for the Best Researcher Award. Her academic achievements, collaborative spirit, and consistent commitment to addressing the mental health needs of emerging adults through evidence-based research make her a truly deserving recipient of this honor.

Jiancheng Xu | Autoimmune Diseases | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Jiancheng Xu | Autoimmune Diseases | Best Researcher Award

Professor at The First Hospital of Jilin University, China

Prof. Dr. Jiancheng Xu is a highly respected academic and medical scientist specializing in clinical laboratory diagnostics, with over two decades of experience in research, diagnostics, and teaching. Serving as Professor, Chief Physician, and Doctoral Supervisor at the First Hospital of Jilin University, he has authored 135 academic papers, including 50 indexed by SCI, and has led 31 funded research projects totaling over 5.64 million yuan. Known for his work on diabetes complications, bacterial resistance, and machine learning applications in laboratory science, Prof. Xu has also contributed to drafting expert consensus documents, issuing local standards, and advancing diagnostic science through books, patents, and active involvement in national medical associations.

profile

orcid

Education

Prof. Xu’s educational path is grounded in clinical laboratory medicine, where he earned his medical doctorate with a specialized focus on laboratory diagnostics. His comprehensive training in clinical biochemistry, microbiology, molecular diagnostics, and statistical methods has enabled him to advance the standardization of laboratory practices and contribute to the development of new diagnostic assays. This education has provided a strong foundation for his extensive clinical and academic career, empowering him to bridge the gap between patient care and laboratory innovation.

Experience

With 23 years of hands-on clinical laboratory diagnostics practice, Prof. Xu has served in critical positions at the First Hospital of Jilin University. As Deputy Director of the Inspection Department, he has shaped quality control practices, participated in national standard-setting, and steered major diagnostic research projects. His vast experience encompasses the development of diagnostic reagents, machine learning-based prediction models, and high-throughput molecular testing. Additionally, his leadership in professional societies and educational programs reflects his broader commitment to advancing the field of laboratory medicine across China.

Research Interest

Prof. Xu’s primary research interests lie in the study of diabetes complications, antimicrobial resistance mechanisms, laboratory test reference interval standardization, and the development of predictive models using machine learning and large-scale clinical data. His focus on both experimental and clinical research demonstrates a commitment to translating laboratory discoveries into practical diagnostic tools, offering new insights into infectious diseases, metabolic disorders, and personalized medicine.

Award

Throughout his career, Prof. Xu has been nominated for numerous prestigious awards recognizing his groundbreaking work in laboratory medicine. His contributions have been acknowledged through his election to committee roles in the Laboratory Medicine Branch of the Chinese Medical Association, the Sino-Japanese Medical Science and Technology Exchange Association, and several innovation-focused health organizations. These nominations and awards reflect his outstanding service in advancing diagnostic research, clinical application, and medical education.

Publication

Prof. Xu has authored numerous influential papers, including:

“Characterisation and analysis of linear epitopes corresponding to SARS-CoV-2 outbreak in Jilin Province, China,” Journal of Medical Virology (2022), cited for advancing knowledge in viral diagnostics;

“Evaluation among trace elements, clinical parameters and type 1 diabetes according to sex,” Journal of Trace Elements in Medicine and Biology (2023), widely referenced in diabetes research;

“Evaluating the role of SARS-CoV-2 target genes based on two nucleic acid assay kits,” Frontiers in Public Health (2022), influencing COVID-19 testing protocols;

“Potential Predictive Value of miR-125b-5p, miR-155-5p and Their Target Genes in the Course of COVID-19,” Infection and Drug Resistance (2022), cited for its insights on biomarkers;

“Development of a machine learning-based risk prediction model for cerebral infarction,” Journal of Affective Disorders (2022), advancing AI in medical diagnosis;

“Establishment of gender- and age-specific reference intervals for serum liver function tests among the elderly,” Biochemia Medica (2022), improving geriatric diagnostics;

“An indirect approach for reference intervals establishment of immunoglobulin A, G and M,” Scandinavian Journal of Clinical and Laboratory Investigation (2022), a reference work for clinical laboratories.

Conclusion

 Prof. Dr. Jiancheng Xu epitomizes the qualities celebrated by the Research for Best Researcher Award: intellectual rigor, innovative spirit, leadership, and an unwavering commitment to advancing medical science. His multi-dimensional contributions — from research breakthroughs and patents to scholarly publications and educational leadership — have significantly impacted both clinical practice and the global scientific community. Recognizing Prof. Xu with this award would not only honor his outstanding career but also set a sterling example of excellence for others in the field of medical laboratory science.

Han Hao | Chromatography Techniques | Best Researcher Award

Posted on by sciencefather

Dr. Han Hao | Chromatography Techniques | Best Researcher Award

Master’s Supervisor at Hebei Medical University , China

Dr. Hao Han is an accomplished pharmaceutical scientist and dedicated lecturer at the Institute of Pharmaceutical Sciences, Hebei Medical University. Throughout his academic and professional journey, Dr. Han has consistently demonstrated a commitment to advancing pharmaceutical sciences, particularly in the realms of supramolecular drug delivery systems and pharmaceutical cocrystals. His research contributions stand out for their depth and innovative approach, particularly in optimizing drug combinations for enhanced therapeutic effects. As a scholar, Dr. Han has distinguished himself by combining a meticulous scientific approach with a vision for real-world pharmaceutical applications, enriching the fields of drug formulation and delivery.

profile

scopus

Education

Dr. Han’s educational background reflects a strong foundation in both pharmacy and biopharmaceuticals. He completed his Ph.D. in Pharmaceutics at Hebei Medical University’s School of Pharmaceutical Sciences in July 2023, following a Master of Science in Pharmacy from the same institution in 2020. Earlier, he earned his Bachelor of Engineering degree in Biopharmaceuticals from Fujian Medical University in 2016. This solid academic training has not only given him technical knowledge but also equipped him with the critical thinking and problem-solving skills necessary to tackle complex pharmaceutical research questions.

Experience

Dr. Han’s research experience is both rich and diverse. Currently serving as a Postdoctoral Researcher at Hebei Medical University since October 2023, his focus lies in the burgeoning field of supramolecular pharmaceuticals. Prior to his postdoctoral appointment, he was deeply engaged in pharmaceutical research throughout his doctoral and master’s studies, contributing substantially to understanding the synergistic mechanisms of drug combinations, preclinical evaluations, and the development of pharmaceutical cocrystals. His scientific work elegantly bridges theory with application, often aiming to improve drug efficacy and reduce side effects through novel formulation strategies.

Research Interest

Dr. Han’s research interests are deeply rooted in the rational design of supramolecular drug delivery systems, preclinical evaluation of pharmaceutical cocrystals, and synergistic drug action mechanisms. His primary scientific focus revolves around enhancing drug bioavailability and therapeutic performance through innovative molecular designs and formulation strategies. By dissecting the interaction mechanisms between co-crystal components and exploring their synergistic effects, Dr. Han aims to create efficient, safer, and more targeted therapeutic agents, offering new solutions for complex diseases, particularly cancer.

Award

Dr. Han’s exceptional research contributions have earned him recognition in both academic and professional circles. His works have been highly cited, a testament to the relevance and influence of his scientific findings in the global pharmaceutical community. While his awards and nominations are still accumulating as he progresses in his academic career, the strength of his publications and collaborations underscores his reputation as a promising leader in pharmaceutical sciences.

Publication

Dr. Hao Han has made substantial contributions to the field of pharmaceutical sciences, with a focus on supramolecular drug delivery systems and pharmaceutical cocrystals, reflected in his published research in internationally recognized journals.

Han Hao, Xinming Jia, Tiantian Ren, Yingfeng Du, Jing Wang. “Novel insight into the mechanism underlying synergistic cytotoxicity from two components in 5-Fluorouracil-phenylalanine co-crystal based on cell metabolomics.” European Journal of Pharmaceutics and Biopharmaceutics, 2022, 180, 181–189. This publication has been cited by several follow-up studies, reflecting its significance in the development of synergistic cytotoxic drug designs.

Han Hao, Tiantian Ren, Cuilu Quan, Jing Wang. “Chiral 5-fluorouracil-arginine cocrystals screened by wet powder grinding method: Leading to synergistic anti-tumor and alleviate cardiotoxicity.” Powder Technology, 2024, 436, 119487. This paper has been cited for its innovative approach to enhancing anticancer drug effects while reducing side effects.

Han Hao, Yao Zhang, Xiaoxiao Hu, Wei Guo, Caiqin Yang, Jing Wang. “Cocrystallization of 5-fluorouracil with gallic acid: A novel 5-fluorouracil cocrystal displaying synergistic anti-tumor activity both in oral and intraperitoneal injection administration.” European Journal of Pharmaceutics and Biopharmaceutics, 2023, 187, 12-23. Widely referenced for its clinical application potential in oncology.

Xin-ming Jia, Han Hao, Qian Zhang, Meng-xin Yang, Nan Wang, Shi-lin Sun, Ze-nan Yang, Yi-ran Jin, Jing Wang, Ying-feng Du. “The bioavailability enhancement and insight into the action mechanism of poorly soluble natural compounds from co-crystals preparation: Oridonin as an example.” Phytomedicine, 2024, 122, 155179. This paper has been cited by researchers interested in enhancing the bioavailability of natural products.

Lina Zhang, Yutao Jia, Han Hao, Mi Wang, Jing Wang. “Mitochondria-targeted liposome-enveloped covalent organic framework co-delivery system for enhanced tumor therapy.” Microporous and Mesoporous Materials, 2022, 344, 112198. This innovative nanotechnology research has been cited for its promising therapeutic applications.

Zhichuan Xin, Yanting Shen, Han Hao, Lina Zhang, Xiaoxiao Hu, Jing Wang. “Hyaluronic acid coated mesoporous carbon-copper peroxide for H2O2 self-supplying and near-infrared responsive multi-mode breast cancer oncotherapy.” Colloids and Surfaces B: Biointerfaces, 2022, 218, 112776. Frequently cited in the field of multifunctional drug delivery systems for cancer treatment.

Mi Wang, Lina Zhang, Han Hao, Xiaoxiao Hu, Zhichuan Xin, Yanyan Zhu, Yanting Shen, Jing Wang. “Synergistic H2O2 self-supplying and NIR-responsive drug delivery nanoplatform for chemodynamic-photothermal-chemotherapy.” Colloids and Surfaces B: Biointerfaces, 2022, 213, 112412. This work has gained citations for its creative integration of photothermal and chemodynamic therapy concepts.

Conclusion

Dr. Hao Han exemplifies the qualities of an outstanding researcher through his dedication, innovation, and scholarly excellence. His contributions are not only valuable to the scientific community but also hold promising implications for patient care and therapeutic advancement. Given his research achievements, depth of knowledge, and consistent publication in respected journals, Dr. Han is a highly deserving candidate for the Best Researcher Award.

Irene Gómez | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Dr. Irene Gómez | Molecular Biology | Best Researcher Award

Investigador Postdoctoral at Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Spain

Irene Gómez Delgado is a passionate and highly skilled postdoctoral researcher working at the Health Research Foundation of Clínico San Carlos Hospital, where she specializes in biomedicine, medical microbiology, and environmental risks. She has shown exceptional dedication to scientific discovery, focusing on the genetic and molecular basis of complex diseases, particularly in the area of immunology and nephrology. Irene’s collaborative spirit, commitment to rigorous methodology, and enthusiasm for public science engagement have marked her as an emerging leader in her field.

profile

orcid

Education

Irene Gómez Delgado’s academic journey reflects both excellence and depth, beginning with her Bachelor’s Degree in Biology from Universidad Complutense de Madrid, earned in 2016. She continued her academic pursuit with a Master’s Degree in Immunology Research from the same university in 2017, equipping her with advanced knowledge of immune system mechanisms. She culminated her formal education by earning a PhD in Molecular Bioscience at Universidad Autónoma de Madrid in 2022, where she developed a strong foundation in molecular biology, genetic research, and experimental design, all of which continue to influence her contributions to biomedical science.

Experience

Irene has steadily advanced her scientific career through key research roles, beginning as a predoctoral researcher at the Health Research Foundation of La Paz University Hospital from 2017 to 2022, where she gained comprehensive experience in molecular biology, laboratory supervision, and project execution. Since 2022, she has been working as a postdoctoral researcher at Clínico San Carlos Hospital’s Laboratory of Genetic and Molecular Basis of Complex Diseases. Alongside her research, Irene has co-directed Master’s Final Projects and supervised undergraduate students and laboratory technicians, showing strong leadership and mentorship capabilities.

Research Interest

Irene’s research interests lie primarily in understanding the molecular and genetic mechanisms underlying immunological and nephrological diseases. Her scientific focus includes studying complement system dysregulation, genetic variants related to immune system proteins, and mitochondrial alterations in immune cells. Her work also extends to infectious disease complications, including severe COVID-19 immune responses, making her research impactful for both rare disease understanding and global health challenges.

Award

Irene Gómez Delgado has been recognized for her scientific achievements through multiple awards. In 2023, she was honored with the Extraordinary Doctorate Award by Universidad Autónoma de Madrid, celebrating the outstanding quality and impact of her doctoral work. She also received the Poster Communication Award from the European Complement Network in 2022 for her contribution at the 18th European Meeting on Complement in Human Disease held in Bern, Switzerland. These awards highlight her scientific excellence and growing reputation in the immunology and nephrology research communities.

Publication

Dr. Gómez Delgado has co-authored several peer-reviewed scientific articles that contribute to the advancement of biomedical research.

Long term mitochondrial and metabolic impairment in lymphocytes of subjects who recovered after severe COVID-19 — published in 2025 in Cell Biology and Toxicology.

Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production — published in 2024 in International Journal of Molecular Sciences.

Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome — published in 2021 in Frontiers in Immunology.

Low factor H-related 5 levels contribute to infection-triggered haemolytic uraemic syndrome and membranoproliferative glomerulonephritis — published in 2021 in Clinical Kidney Journal.

High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B — published in 2018 in Frontiers in Immunology.

Contribution of functional and quantitative genetic variants of Complement Factor H and Factor H-Related (FHR) proteins on renal pathology — published in 2022 in Nefrología.

Altered expression of FHR-1 and FHR-2 glycoforms in IgA nephropathy patients — published in 2024 in European Journal of Immunology (Meeting Abstract).

Conclusion

Dr. Irene Gómez Delgado exemplifies the qualities of a leading researcher through her pioneering contributions to immunology and molecular medicine, her active engagement in scientific dissemination, and her commitment to mentorship and collaborative research. Her career trajectory reflects an unwavering pursuit of knowledge and societal impact, which makes her a deserving and inspiring nominee for the Research for Best Researcher Award.

Eleftherios Pelechas | Rheumatology | Best Researcher Award

Posted on by sciencefather

Dr. Eleftherios Pelechas | Rheumatology | Best Researcher Award

Scientific Associate in Rheumatology at Hatzikosta Hospital of Ioannina, Greece

Dr. Eleftherios Pelechas is a distinguished rheumatologist, scientific associate, and researcher currently affiliated with the Hatzikosta General Hospital of Ioannina in Greece. His academic path and professional journey reflect a deep commitment to advancing the field of rheumatology and internal medicine. With an impressive academic and research background, Dr. Pelechas has become a notable contributor to scientific literature, particularly in the areas of rheumatic and autoimmune diseases. Beyond clinical practice, his expertise also encompasses musculoskeletal ultrasonography, teaching, and medical writing, enriching both professional and academic communities through lectures, peer-reviewed publications, and book chapters.

profile

google scholar

Education

Dr. Pelechas completed his medical studies at the University of Medicine and Pharmacy “Gr. T. Popa” in Iași, Romania, where he earned his “Doctor Medic” diploma with an excellent grade. He furthered his academic qualifications with a PhD in Epidemiology, focusing on gastroesophageal reflux disease, and a Master’s degree in Healthcare Management from the Open University of Cyprus. His education also includes a certification in Medical Acupuncture from the Greek Institute of Acupuncture, and specialized musculoskeletal ultrasound training under the European League Against Rheumatism (EULAR). His educational pursuits highlight a versatile background, combining clinical excellence with healthcare management and diagnostic imaging expertise.

Experience

Dr. Pelechas’ professional journey spans a wide spectrum of medical settings, from rural healthcare units and military medical service to internal medicine departments and specialized rheumatology centers. He has worked in both Greek and UK hospitals, including Scarborough General Hospital and the University Hospitals of Leicester, gaining extensive emergency care and internal medicine experience. His role at the Rheumatology Department of the University Hospital of Ioannina honed his specialization in autoimmune diseases. Currently, as a scientific associate at Hatzikosta General Hospital and through his private practice, he applies his wide-ranging expertise in clinical rheumatology, providing comprehensive patient care while continuing his academic involvement.

Research Interest

Dr. Pelechas’ research is deeply rooted in the study of rheumatic and autoimmune diseases, with particular emphasis on the epidemiology, diagnosis, and management of these conditions. His work often explores the interface between systemic inflammation and comorbidities like cancer and cardiovascular disorders, and he maintains a strong interest in musculoskeletal ultrasonography as a diagnostic and monitoring tool. His involvement in more than 70 research projects and collaboration with multiple university centers demonstrates his commitment to fostering both clinical and translational research in rheumatology.

Award

Throughout his career, Dr. Pelechas has received notable recognition for his contributions to the field. A highlight is the award from the National Academy of Athens for the “Illustrated Handbook of Rheumatic and Musculo-Skeletal Diseases,” a landmark publication that reflects his dedication to medical education and the dissemination of clear, comprehensive clinical knowledge. His nomination for research awards and his participation in international congresses and scientific advisory boards underscore his recognized status within the academic community.

Publications

Dr. Pelechas has authored several impactful papers and books. Among them:

Pelechas E, Azoicai D. “Improvement of Gastroesophageal reflux in patients with obstructive sleep apnoea treated with continuous positive airway pressure,” J Gastrointestin Liver Dis, 2012; cited by 25 articles.

Pelechas E, Azoicai D. “Gastroesophageal Reflux Disease: epidemiological data, symptomatology and risk factors,” Rev Med Chir Soc Med Nat Iasi, 2013; cited by 19 articles.

Pelechas E, Antoniadis A. “A comparative study of job satisfaction between two regional hospitals in Greece,” Arch Hellen Med, 2013; cited by 15 articles.

Pelechas E, Azoicai D. “Impact of nasal Continuous Positive Airway Pressure on Heart Rhythm in patients with Obstructive Sleep Apnea/Hypopnea syndrome,” Minerva Med, 2014; cited by 18 articles.

Pelechas E, Tsigaridas N et al. “Hospitalized elderly patients due to infection and factors associated with mortality,” Medical Annals of Northwestern Greece, 2014; cited by 20 articles.

Pelechas E, Kaltsonoudis E, Voulgari PV, Drosos AA. “Unmet needs in the treatment of Ankylosing Spondylitis,” presented at ACR Annual Meeting, 2018; cited by 35 articles.

Pelechas E, Kaltsonoudis E, Voulgari PV, Drosos AA. “Maintained Clinical Remission in Ankylosing Spondylitis patients switched from reference Infliximab to its biosimilar,” EULAR Congress Abstracts, 2019; cited by 12 articles.

Conclusion

Dr. Eleftherios Pelechas’s career reflects the qualities of a truly distinguished researcher: intellectual curiosity, dedication to advancing patient care, and continuous scholarly productivity. His contributions to both the academic world and clinical practice stand as a testament to his commitment to excellence in rheumatology research. Through his extensive publication record, teaching, participation in scientific congresses, and ongoing research collaborations, Dr. Pelechas has significantly enriched the field and served as a mentor and model for future researchers. His work has laid new groundwork in the understanding of autoimmune and rheumatic diseases, making him highly deserving of the Best Researcher Award.